GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue394,111340,750327,868287,458
Cost of Revenue124,926114,329118,98663,223
Gross Profit269,185226,421208,882224,235
Operating Expenses
Research Development-52,82656,82144,857
Selling General and Administrative239,189229,595221,714207,270
Non Recurring----
Others----
Total Operating Expenses364,115343,924340,700315,350
Operating Income or Loss29,996-3,174-12,832-27,892
Income from Continuing Operations
Total Other Income/Expenses Net-3,072821294-6,412
Earnings Before Interest and Taxes29,996-3,174-12,832-27,892
Interest Expense----
Income Before Tax26,924-2,353-12,538-34,304
Income Tax Expense1,2471,5041,381-996
Minority Interest----
Net Income From Continuing Ops25,677-3,857-13,919-33,308
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income25,677-3,857-13,919-33,308
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares25,677-3,857-13,919-33,308